Oxaliplatin Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Oxaliplatin Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Feb 25, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
63323-750-10
Dosage Form
Injection
Presentation
Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)
Initial Posting
Feb 25, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.